Oral Oncology

Article	Citations
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection	96
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”	77
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”	73
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”	48
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”	43
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis	40
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review	38
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma	38
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?	36
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples	35
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer	34
Editorial Board/Aims & Scope	34
Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?	34
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies	33
P28 Head and neck cancer cells differentiate resembling their tissue of origin	32
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review	31
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment	31
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis	30
Tumor subtype classification tool for HPV-associated head and neck cancers	30
Comment on: “Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial”	30
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”	29
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”	29
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions	28
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study	28
Comment on: Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1–2, N0) oral cavity squamous cell carcinoma: A matched pair analysis	28

What does margin mean in laryngeal surgery?	28
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]	26
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma	26
Overestimated risk of transformation in oral lichen planus	26
Radiation-induced sarcomas of the craniofacial region: A systematic review	26
Required time for pre-oncological dental management – A rapid review of the literature	26
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma	25
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer	25
Correction to “My letter: Do we recognize oral oncology with accuracy? AI-driven models serve in the diagnosis of oral squamous cell carcinoma”	25
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study	25
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients	25
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study	24
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma	24
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis	24
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–2021	24
Health-related quality of life after free flap reconstruction of maxillary defects: a systematic review and meta-analysis	24
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes	24
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	23
Evaluation of Otolaryngology Provider Bias in Portal Messaging	23
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients	22
Myxoid variant of extramammary myofibroblastoma affecting the buccal mucosa: An extremely rare oral lesion and literature review	22
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection	22
“Time is not to be wasted”	22
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]	22
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis	22
Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation	22
Artificial intelligence for oral cancer diagnosis: What are the possibilities?	22
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study	22
Intrathyroid thymic carcinoma diagnosed following an odontogenic infection: Insights from a rare clinical presentation	21
Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones	21
Management of head and neck cancer around the world: an international survey by the world ear, nose, and throat federation	21
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis	21
ChatGPT: Empowering dentistry with future possibilities	21
Commentary on, “Margin analysis of radical tonsillectomy specimens following transoral robotic surgery”	20
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy	20
Letter to the Editor: Prognostic value of age-adjusted comorbidity scoring in OSCC - a step toward personalized oncology	20
Comment on “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”	20
Commentary on: From mutation maps to clinical impact: Unraveling OSCC genomics in a japanese nationwide cohort	20
Comment on “The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study”	20
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma	20
Completion thyroidectomy for intermediate risk factors after thyroid lobectomy	20
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma	20
Papillary thyroid cancer in black thyroid: A case report	19
O1.3 Awareness of HPV-associated oropharyngeal cancer among the general population and general practitioners in the Netherlands: Cross-sectional study	19
FLASH radiotherapy in head and neck cancer: Myth or reality?	19
P29 Comparison of selected clinical factors and treatment results according to HPV status in patients with oropharyngeal cancer treated with radiotherapy alone or combined with chemotherapy	19
Editorial Board	19
Letter to Editor on, “De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study”	19
Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions	19
P25 The role of ultrasound elastography for clinical neck staging in HPV-related oropharyngeal cancer	19

“In response to “Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia”	18
Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI	18
P35 Spatial proteomics and metabolomics investigations in head & neck cancers	18
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?	18
Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology	18
Editorial Board/Aims & Scope	18
Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma	18
Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions	18
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma	18
Selective autophagy as a potential therapeutic target for oral cancer	18
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer	17
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas	17
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors	17
Palliative care utilization among head and neck cancer patients: A population-based analysis	17
Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma	17
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]	17
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?	17
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma	17
Refining prognosis and Personalizing Therapy: A Step Forward with Machine learning in HPV-Associated head and neck cancer	17
Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial	17
Response to the comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”	17
Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]	16
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients	16
De-escalation in high-risk HPV-positive OPC: critical appraisal of methodology and inference	16
Osteoblastoma of the maxilla: A case report and review of the literature	16
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial	16
Elective neck dissection: Are we bound to outdated concepts?	16
Beyond binary ENE in HPV-related oropharyngeal cancer: Toward standardized reporting and risk stratification	15
Critical appraisal of post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA: promising potential amid methodological c	15
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma	15
Carcinoma of the parotid Gland: A Population-Based study of incidence and treatment outcomes in 1018 patients	15
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials	15
Comment on: Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort	15
The integration of female physiological and social role factors in HRQOL research	15
The importance of early treatment of oral squamous cell carcinoma: Case report	15
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma	15
The case against lingual mucosectomy	15
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma	14
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer	14
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma	14
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma – “Need for incorporation of sub classification of pT4b lesions”	14
Comment on “Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review”	14
Comment on, “Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes”	14
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy	14
A rare case of extranodal Rosai Dorfman disease of zygoma	14
Editorial Board	14
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial	14
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma	14
Correspondence on “Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040”	14
O3.3 Proximity ligation-based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas	14
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)	14
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study	13
Curative approaches for adenoid cystic carcinoma: a multifaceted disease	13
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?	13
Revolutionizing HPV-driven cancer surveillance: A commentary on the validation of the HPV-SEQ liquid biopsy platform	13
Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma	13
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor	13
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery	13
Ferroptosis: An emerging therapeutic target for oral cancer	13
Mitigating survival disparities in head and neck cancer: urgent need to reduce ED-based biopsy delays	13
CD271high cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma	13
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unre	13
Metformin and oral cancer	13
Letter to the editor, “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer”	13
Unfamiliar case of metastatic myxoid leiomyosarcoma of mandible	13
Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma	12
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening	12
Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies	12
Commentary on “Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients”	12
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy	12
Thyroid volumes after intensity‐modulated radiotherapy as predictors of radiation‐induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study	12
Letter to the Editor: “Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma”	12
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy	12
Editorial Board	12
Superficial angiomyxoma affecting the buccal mucosa: A detailed immunohistochemical study and literature review	12
Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC	12
Editorial Board	12
Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis	12
Toward comprehensive optimization of larynx-preserving strategies in MI-LSCC	12
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck	12

Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study	12
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma	12
Pain management following transoral robotic surgery for oropharyngeal squamous cell Carcinoma: A systematic review	12
Tongue cancer in non-smoking and non-alcoholic mother and daughter	12
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patients	12
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: RestorabiteTM	11
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma	11
Letter to the editor “The use of 3D computer-aided design to optimize photoimmunotherapy catheter placement”	11
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma	11
Comment on: “The role of adjuvant radiotherapy in relation to tumor size for bone-invasive pT4aN0 oral squamous cell carcinoma-A retrospective observational matched cohort study”	11
Editorial Board/Aims & Scope	11
Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequentia	11
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments	11
Perioperative immunotherapy for head and neck cancer: from early successes to clinical challenges in relapsed and/or metastatic disease	11
Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan	11
O1.2 Single cell RNA sequencing allows mapping of HPV transcripts in head and neck cancer epithelial cells	11
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice	11
Anti-epidermal growth factor receptor targeted therapy-associated ulcerations	11
O3.2 Loss of LRP1B expression drives chemo and radiation resistance in HPV-positive head and neck cancer	11
Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131]	11
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer	11
Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies	11
Perioral reconstruction by submental flap	11
The impact of physician’s characteristics on decision-making in head and neck oncology: Results of a national survey	11
Randomizing treatment is not equivalent to validating biomarker-guided intensification in high-risk nasopharyngeal carcinoma	10
Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy	10
Letter to the editor, “The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.”	10
Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions	10
Neoadjuvant chemotherapy combined with anti-PD-1 monoclonal antibody in locally advanced resectable oral squamous cell carcinoma: efficacy evaluation and prediction	10
The state of virtual surgical planning in maxillary Reconstruction: A systematic review	10
Lung cancer metastases to the oral cavity: Report of two cases and review of literature	10
The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer	10
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-	10
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study	10
Integrative analysis of aging-related immune parameters reveals prognostic and immunotherapeutic implications in head and neck squamous cell carcinoma	10
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer pat	10
Prognostic factors in surgically treated malignant salivary gland tumors	10
Authors reply to comment by Irene Lafuente-Ibáñez de Mendoza and Aguirre-Urizar JM	10
Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck	10
Commentary on, “Oncologic significance of the lateral margin in buccal cancer.”	10
Commentary on “Predicting reactive Gastrostomy-Tube placement after head and neck free flap Reconstruction”	10
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores	10
Corrigendum to “Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer” [Oral Oncol. 51 (2015) 565–569]	10
Correlation between radiological, macroscopic and microscopic depth of invasion in oral squamous cell carcinoma: A prospective study using contrast-enhanced computed tomography	10
Corrigendum to “Flash radiotherapy-gateway to promised land or another mirage” [Oral Oncol. 139 (2023) 106342]	10
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study	10
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 s	10
When histology tells a different story: salivary duct carcinoma in disguise	10
Corrigendum to “Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer” [Oral On	10
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma	10
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens	10
Ensemble learning-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma	10
Commentary on, “Prevalence of oral human papillomavirus infection among adult men and women in Taiwan (PILLOT).”	10
Personalized intraoral devices in the era of high-technology head and neck radiotherapy: A resource to be explored	10
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer	10
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area	10
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells – Multifunctional therapeutic approach against oral cancer	10
Genetic characteristics of a highly metastatic basal cell adenocarcinoma arising in buccal mucosa	9
Oncological outcomes of pathological extranodal extension (pENE) in oral squamous cell carcinoma (OSCC): A proposal to refine the current staging	9
The association of frailty with morbidity and mortality following major mucosal head and neck surgery	9
In reply to “Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study”	9
Metastasis to the ciliary body and iris from a parotid carcinoma	9
Advancing precision prevention: enhancing the hypoxia–microbiota framework in oral potentially malignant disorders	9
Establishing a role for the oral microbiome in infectious complications following major oral cavity cancer surgery	9
Donor-site morbidity in sarcopenic patients: An overlooked pathway to complications	9
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas	9
Comments on: The role of adjuvant radiotherapy in relation to tumor size for bone-invasive pT4aN0 oral squamous cell carcinoma − A retrospective observational matched cohort study	9
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study	9
A rare case of Merkel cell carcinoma on the craniofacial region and characterization of its aneuploid CD31− CTCs and CD31+ CTECs expressing EpCAM or Ki-67	9
Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas	9
Delineating atypia and dysplasia – Addressing the grey zone	9
Critical reflections on the clinical implementation of 3D-Printed oral stents for radiotherapy patients	9
Postoperative complications of neck dissection for head and neck squamous cell carcinoma: a systematic review and meta-analysis	9
Comment on “Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients”	9
Selective tracheostomy in oral cancer reconstruction with myomucosal flaps: Outcomes and an appraisal of published risk scores	9
Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature	9
In regard to Riddhima Agarwal et al	9
Relationship between GLUT-1 and HIF-1α: Is it a friend or foe for studying the biological behaviour of head-and-neck tumorigenesis?	9
Bridging the gap: From dosimetric sparing to patient-reported functional benefit in the GUARD trial	9
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months	9
Aurora kinase in oral cancer: A potential therapeutic target to improve treatment efficiency	9
Scapula or Fibula?: Prospective data-driven decision criteria for flap selection in mandibular reconstruction planning	9
Advancing precision radiotherapy through AI/ML in appliance design and patient outcome prediction: a complement to the GUARD trial	9
Oral cancer screening in India: a secondary analysis of disparities using national family health survey data	9
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma	9
Esophageal dysmotility in head and neck cancer survivors: a critical step forward and the path ahead!	9
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinoma	9
Long-term health-related quality of life in oral cancer survivors following microvascular tongue reconstruction	8
Treatment outcomes of sinonasal adenoid cystic carcinoma: a single-center experience	8
Immune stratification in HPV-negative HNSCC: prognostic significance and prediction of immunotherapy response	8
The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer	8
Mucinous adenocarcinoma of the base of the tongue: A case report	8
From infection to immortality: The role of HPV and telomerase in head and neck cancer	8
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity	8
Papillary thyroid carcinoma arising in thyroglossal duct cyst: A case report with long term follow-up	8